Taking everything into account, TRVI scores 3 out of 10 in our fundamental rating. TRVI was compared to 191 industry peers in the Pharmaceuticals industry. While TRVI has a great health rating, there are worries on its profitability. TRVI does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

TRVI had negative earnings in the past year.
TRVI had a negative operating cash flow in the past year.
TRVI had negative earnings in each of the past 5 years.
TRVI had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -23.00%, TRVI perfoms like the industry average, outperforming 58.12% of the companies in the same industry.
TRVI has a Return On Equity of -24.16%. This is in the better half of the industry: TRVI outperforms 65.44% of its industry peers.

		Industry Rank	Sector Rank
ROA	-23%
ROE	-24.16%
ROIC	N/A

ROA(3y)-33.14%

ROA(5y)-51.42%

ROE(3y)-36.8%

ROE(5y)-85.78%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

TRVI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

TRVI has more shares outstanding than it did 1 year ago.
TRVI has more shares outstanding than it did 5 years ago.
TRVI has a better debt/assets ratio than last year.

2.2 Solvency

TRVI has an Altman-Z score of 86.00. This indicates that TRVI is financially healthy and has little risk of bankruptcy at the moment.
TRVI has a better Altman-Z score (86.00) than 97.91% of its industry peers.
There is no outstanding debt for TRVI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	86

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 21.93 indicates that TRVI has no problem at all paying its short term obligations.
TRVI has a Current ratio of 21.93. This is amongst the best in the industry. TRVI outperforms 91.10% of its industry peers.
A Quick Ratio of 21.93 indicates that TRVI has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 21.93, TRVI belongs to the top of the industry, outperforming 91.62% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	21.93
Quick Ratio	21.93

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

TRVI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.91%, which is quite good.

EPS 1Y (TTM)15.91%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%38.46%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, TRVI will show a small growth in Earnings Per Share. The EPS will grow by 7.27% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y20.29%

EPS Next 2Y-1.19%

EPS Next 3Y-7.42%

EPS Next 5Y7.27%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TRVI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TRVI. No positive earnings are expected for the next year.